Tata Chemicals reported a sharp widening of its consolidated net loss in Q4FY26, weighed down by a substantial exceptional charge arising from goodwill impairment in the US, even as the board recommended a dividend of ₹11 per share. The audited consolidated and standalone financial results for the quarter and financial year ended March 31, 2026, approved by the Board at its meeting held on May 4, 2026, were subsequently published in Business Standard (English), The Free Press Journal (English), and Navshakti (Marathi) on May 5, 2026, in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The full format of the results is available on the Stock Exchange websites and on the company's website at www.tatachemicals.com .

Q4FY26 Consolidated Financial Performance

The company's consolidated net loss for Q4FY26 surged to ₹2,132 Cr, compared to a loss of ₹74 Cr in Q4FY25, marking a sharp year-on-year deterioration. Revenue from operations declined modestly to ₹3,438 Cr from ₹3,509 Cr in Q4FY25, a decline of 2%, driven by lower realisations mainly due to lower exports from the US, partially offset by higher volumes in India. EBITDA stood at ₹274 Cr, down from ₹327 Cr in Q4FY25, impacted by subdued pricing across all geographies and an increase in fixed costs, including due to the steep depreciation of the Indian Rupee.

The following table summarises the key consolidated financial metrics for Q4FY26 on a year-on-year basis:

An exceptional charge of ₹1,837 Cr was recognised on account of impairment of goodwill in the US, along with a ₹159 Cr write-off of deferred tax assets, together constituting the primary driver of the widened net loss. Net debt (without leases) as on March 31, 2026, stood at ₹5,961 Cr, compared to ₹4,884 Cr as on March 31, 2025. The debt-to-equity ratio stood at 0.36.

The following table presents key consolidated financial ratios:

Q4FY26 Standalone Performance

On a standalone basis, Tata Chemicals delivered a relatively resilient performance, supported by higher volumes and disciplined cost management. The following table presents key standalone metrics for Q4FY26:

The Mithapur Gujarat facility achieved a significant milestone, recording production of 1 MTPA of Soda Ash in FY26.

Full Year FY26 Consolidated and Standalone Highlights

For the full year FY26, consolidated revenue from operations stood at ₹14,584 Cr, down 2% compared to FY25 revenue of ₹14,887 Cr, owing to pricing pressure across all regions and lower volumes except in India and Kenya. EBITDA for FY26 came in at ₹1,805 Cr versus ₹1,953 Cr in FY25. An exceptional charge of ₹1,956 Cr was recognised for FY26, covering goodwill impairment in the US (₹1,837 Cr), the impact of the labour code in India (₹54 Cr), and costs related to the UK soda ash plant (₹65 Cr). Additionally, ₹182 Cr of deferred tax assets were written off in the US. Non-Soda Ash revenue grew by 14% over FY25, from ₹6,118 Cr to ₹6,946 Cr, in line with the company's focus on growing its non-cyclical business.

The following table presents key FY26 full-year consolidated and standalone metrics:

Segment-Wise Performance

The investor presentation provided a detailed unit-wise breakdown of Q4FY26 performance across geographies. India revenues rose to ₹1,254 Cr from ₹1,219 Cr in Q4FY25, with EBITDA at ₹216 Cr versus ₹230 Cr in Q4FY25. The US segment reported revenues of ₹1,184 Cr, down from ₹1,316 Cr in Q4FY25, with EBITDA at ₹36 Cr versus ₹80 Cr in Q4FY25, impacted by unremunerative export realisations. The UK segment posted revenues of ₹338 Cr versus ₹417 Cr in Q4FY25, while Kenya revenues were ₹154 Cr versus ₹158 Cr in Q4FY25. Rallis revenues came in at ₹456 Cr versus ₹430 Cr in Q4FY25.

The following table summarises segment-wise Q4FY26 revenues and EBITDA:

Sales Volumes and Balance Sheet

Consolidated sales volumes for Soda Ash, Bicarb, and Salt stood at 1,344 Kts in Q4FY26, compared to 1,393 Kts in Q3FY26 and 1,339 Kts in Q4FY25. For the full year FY26, total volumes were 5,358 Kts versus 5,218 Kts in FY25. On the balance sheet, consolidated total assets stood at ₹39,031 Cr as on March 31, 2026, versus ₹37,780 Cr as on March 31, 2025. Equity and reserves were ₹21,206 Cr, while total borrowings (non-current and current, including lease liabilities) were ₹8,001 Cr. Capex spend for FY26 was ₹1,205 Cr, lower than the prior year by ₹801 Cr, as major expansion of soda ash and bicarb was completed in FY25.

The following table presents the consolidated balance sheet summary:

Strategic Developments and Operational Milestones

During the quarter, Tata Chemicals completed the acquisition of Novabay Pte. Limited, Singapore on March 19, 2026, a move aligned with its strategy of expanding high-margin specialty chemicals and strengthening its presence in key global markets. The Board also approved a ₹100 Cr investment to debottleneck salt capacity at the Mithapur plant by 82,500 TPA. Additionally, a 50 kT Electric calciner soda ash plant in Kenya was operationalised during the quarter. For the full year, the Pearl Silica facility with a capacity of 3,000 MTPA at Cuddalore, Tamil Nadu, was commissioned in November 2025, and the FOS L55 facility with a capacity of 4,500 MTPA at Mambattu was commissioned in December 2025, alongside a 5 MW solar plant and Solar Pond in Kenya. The company also laid the foundation stone for a greenfield IVSD manufacturing facility in Ramanathapuram at Conversion Conclave 2026 on February 12, 2026.

The following table summarises key upcoming capital projects:

Management Commentary

Commenting on the results, R. Mukundan, Managing Director & CEO, Tata Chemicals Limited, noted that global soda ash markets remained adequately supplied during Q4FY26, with the supply overhang continuing to exert pressure on pricing. He highlighted that the challenging external environment, amid ongoing geopolitical tensions in the Middle East, led to uncertainty and limited visibility on any immediate change in market conditions. Disruptions stemming from the Middle East conflict have resulted in higher shipping and raw material costs, though the company noted these are mostly passed on to customers. He added that the company's standalone performance was supported by higher volumes and disciplined cost management, while the consolidated performance was sharply impacted by continuing unsustainable unremunerative prices across geographies, particularly in Southeast Asia.

On the demand outlook, the company noted that global demand is expected to remain flat due to weak economic conditions, while India continues to demonstrate strong growth. China and the US are experiencing steady demand. Pricing is anticipated to stay stable, mainly influenced by rising energy costs. Looking ahead, future demand for the global soda ash segment is expected to be driven by emerging applications such as solar glass and lithium carbonate. The company's focus remains on safeguarding margins, preserving cash flows, and maintaining a strong and resilient balance sheet, with improvements in margins and profitability expected in the coming quarters from effective management, stronger supply chains, and financial discipline.

Earnings Call and Dividend

The audio recording of the analysts/investors call on the audited consolidated and standalone financial results for the quarter and financial year ended March 31, 2026, held on May 4, 2026, has been filed with the stock exchanges. The results were approved by the Board at its meeting held on the same day and subsequently published in newspapers on May 5, 2026. Notwithstanding the challenging quarterly and annual results, the board has recommended a dividend of ₹11 per share, underscoring a continued focus on returning value to shareholders.

Tata Chemicals is at the centre of a significant corporate development as both Vice Chairmen of Tata Trusts — Venu Srinivasan and Vijay Singh — have publicly spoken in favour of listing Tata Sons, according to a report by CNBCTV18. The development marks a notable alignment of views at the top of the Tata Trusts leadership on the subject of bringing Tata Sons to the public markets.

Key Developments

The statements by both Vice Chairmen have prompted formal deliberation at the Tata Chemicals level, with the company expected to address their remarks. Adding further significance to the matter, a Tata Trust meeting has been scheduled for May 8, which is set to take up two agenda items, as reported by CNBCTV18.

No additional financial figures or operational details were included in the source report beyond these developments.